2009-2010 CGR
2009-2010
Cardiovascular Medicine Grand Rounds
“Mitral Valve Surgery”
Irving L. Kron, MD
Professor of Surgery
Chair, Department of Surgery
University of Virginia
Charlottesville, VA
- discuss the results and indications for mitral valve repair
- describe the rationale for NHLBI trials in ischemic mitral valve disease
“Device Therapy in Heart Failure: The Good and Bad of Evolving Technologies for American’s Healthcare”Adrian F. Hernandez, MD, MHS
Assistant Professor, Duke University School of Medicine
Associate Editor, American Heart Journal
Duke University
Durham, NC
- discuss the evolving evidence for device-based therapies for heart failure
- evaluate the limitations and gaps in knowledge of device-based therapy in heart failure
“Cardiovascular MRI without Resorting to Breathholds: Applications Suitable to Acutely Ill Patients”
Andrew E. Arai, MD
Senior Investigator
Laboratory of Cardiac Energetics
National Heart, Lung, and Blood Institute
Bethesda, MD
- describe limitations of conventional cardiac magnetic resonance (CMR) methods performed on short breathholds, particularly with regard to acutely ill patients
- identify new MRI methods that can produce high quality CMR images without a need for a breathhold
- discuss clinical applications that can benefit from high quality non-breathhold CMR methods
“Cryoablation of Atrial Fibrillation”
Kenneth A. Ellenbogen, MD
Professor of Medicine
Vice-Chairman of Cardiology
Pauley Heart Center
Virginia Commonwealth University
Richmond, VA
- discuss new treatments of atrial fibrillation
- identify the role of new antiarrhythmic agents
- describe the role of ablation
- discuss he prognosis of atrial fibrillation
“A Combined Minimal Invasive Epicardial and Percutaneous Endocardial Ablation for the Treatment of Atrial Fibrillation”
Mark I. M. LaMeir, MD
Department of CardiothoracicSurgery
University Hospital of Maastricht
Maastricht, The Netherlands
- discuss the treatment of atrial fibrillation
- describe hybrid procedures
- discuss collaboration between EP and cardiac surgeons
“Genomics”
Geoffrey S. Ginsburg, MD, PhD
Director, Center for Genomic Medicine
Duke University Institute of Genomic
Sciences & Policy
Duke University
Durham, NC
- describe the basic concepts of genomic analysis as well as of “personalized medicine” and the relevant technological breakthroughs that lead to the possibilities of personalized cardiovascular medicine
- identify the novel approaches that the genome is allowing in classifying cardiovascular disease and cardiovascular events and the challenges that genomic and personalized medicine face before the concepts can be fully embraced and adopted clinically.
“Clinical Trial: TRILOGY-ACS (prasugrel)”
Matthew T. Roe, MD, MHS
Assistant Professor of Medicine
Duke University
Durham, NC
- describe the duration of anti-platelet benefit post-MI
- discuss the balancing of ischemic vs bleeding risks
- identify recent advances in anti-platelet therapies
- discuss future approaches and directions
No CGR
“Preventive Cardiology in the 21st Century”
Carlos R. Ayers, MD
Edward W. and Betty Knight Scripps
Professor of Internal Medicine
in Preventive Cardiology
Cardiovascular Division
University of Virginia Health System
School of Medicine
Charlottesville, VA
- discuss the evolution of drug therapy in hypertension
- discuss a comprehensive approach to treating dyslipidemia
- describe the role of insulin resistance in cardiovascular disease
AHA National Conference in Orlando, FL
“Update on Infective Endocarditis”
W. Michael Scheld, MD
Professor of Internal Medicine and
Clinical Professor of Neurosurgery
Bayer-Gerald L. Mandell Professor of Infectious Diseases
Division of Infectious Diseases and International Health
University of Virginia Health System
Charlottesville, VA
- discuss the changing epidemiology of infective endocarditis
- describe the appropriate antimicrobial management for the most common forms of infective endocarditis on native and prosthetic valves
“Retiming the Failing Heart: Recent Developments in Cardiac Resynchronization Therapy”
Kenneth C. Bilchick, MD
Assistant Professor of Medicine
Cardiovascular Division
University of Virginia Health System
Charlottesville, VA
- identify three clinical conditions causing left ventricular mechanical dyssynchrony and compare the pathophysiology associated with these conditions.
- describe three reasons why a patient meeting standard clinical criteria for resynchronization may have a suboptimal response to this therapy.
- describe the proposed “molecular signature” of dyssynchrony-heart failure that may be responsive to resynchronization.
- identify the potential impact of three recent CRT trials (MADIT-CRT, REVERSE, PACE) for extending current indications for resynchronization.
- discuss the role of cardiac magnetic resonance imaging for identifying CRT responders and how to identify candidates for a related comprehensive CRT study at UVA.
“MRI of Myocardial Function: Research”
Frederick H. Epstein, PhD
Associate Professor of Radiology,
Radiology Research
University of Virginia Health System
Charlottesville, VA
- define quantitative myocardial strain imaging and describe state-of-the-art echo and MRI methods.
- provide at least two reasons why quantitative CMR might be advantageous compared to qualitative imaging.
- describe the parameters of myocardial mechanics (displacement, strain, twist, and torsion) and understand normal values as measured by MRI.
“What Have You Done for Me Lately; Why the Hell Should I Join the ACC?”
C. Michael Valentine, MD
President, Cardiovascular Group of Centra
Board of Trustees, American College of Cardiology
Co-Chair, Cardiovascular Leadership Institute
Lynchburg, VA
- describe current advocacy initiatives and role in Health Care Reform of National ACC in Washington, DC
- identify current, exciting initiatives ongoing in the State of Virginia supported by the ACC: VHAC, D2B, H2H
- describe current CHF management systems and opportunities
- identify inpatient and outpatient collaboration and electronic medical systems and ongoing pilots in Virginia
“Potential of the Epicardium in Electrophysiology”
Srijoy Mahapatra, MD
Assistant Professor of Medicine
Cardiovascular Division
University of Virginia Health System
Charlottesville, VA
- identify the indications for epicardial VT ablation
- discuss the new surgical/catheter based AF ablations
- describe the complications associated with epicardial procedures
“Gender and Racial Disparity in the Diagnosis and Management of Atrial Fibrillation”
Pamela K. Mason, MD
Assistant Professor of Medicine,
Cardiovascular Medicine
University of Virginia Health System
Charlottesville, VA
- describe the epidemiology of atrial fibrillation
- discuss the influence that gender and race has on the diagnosis and management of atrial fibrillation
“Percutaneous Left Ventricular Support Devices”
Michael Ragosta, III, MD
Associate Professor of Medicine,
Cardiovascular Medicine
University of Virginia Health System
Charlottesville, VA
- describe the hemodynamic principles underlying the various modes of left ventricular support devices
- identify the indications, contraindications and potential complications for percutaneous left ventricular assist devices.
“Why Auscultation Still Counts: The History of the Stethoscope”
Alan J. Binder, MD
Associate Clinical Professor of Medicine,
Cardiovascular Medicine
University of Virginia Health System
Charlottesville, VA
- discuss the history of the cardiac examination and its current role in practice.
Women’s Heart Month
“Vascular Disease: A Cardiologist’s Perspective”
Jason Call, M.D.
Assistant Professor of Medicine
Cardiovascular Medicine
University of Virginia Health System
Charlottesville, VA
- describe the clinical spectrum of vascular disease.
- identify some of the non-invasive testing available in the evaluation of a patient with vascular disease.
- discuss some of the invasive therapies available to patients with vascular disease.
Women’s Heart Month
“How the Sinus Node Signals Distress”
J. Randall Moorman, MD
Professor of Medicine,
Cardiovascular Medicine
University of Virginia Health System
Charlottesville, VA
- describe the control of sinus node firing rate by extracellular and intracellular signaling processes.
- recognize altered heart rate variability as a sign of global distress
“Use of Device-based Data to Manage Patients with Heart Failure”
Sandeep Kamath, MD
Assistant Professor of Medicine
Cardiovascular Medicine
University of Virginia Health System
Charlottesville, VA
- describe the role of device-based diagnostics in the management of moderate to advanced heart failure.
- identify the present and future role of implantable hemodynamic monitoring and remote monitoring in the management of moderate to advanced heart failure.
ACC Conference Orlando Mar 14-16
“Percutaneous Coronary Revascularization in the Setting of Impaired Ventricular Function”
George Vetrovec, MD
Professor and Chair, Cardiovascular Division
Associate Chair for Clinical Affairs, IM
Virginia Commonwealth University
Richmond, VA
“Molecular Imaging of Atherosclerosis”
Kimberly Kelly, PhD
Asst Prof of Biomedical Engineering
University of Virginia
Charlottesville, VA
- discuss development of molecularly targeted imaging agents
- recognize imaging therapeutic response
“Interventional Strategies in Acute Coronary Syndromes”
Lawrence W. Gimple, MD
Professor of Medicine (Cardiology)
Donald C. Barnes Professor
of Cardiology in Internal Medicine
University of Virginia
- describe the role of coronary intervention for patients with ACS
- evaluate the timing of pharmacologic interventions in such patients
- identify the role of newer agents in patients with ACS
“Cardiac MRI”
Matthais Friedrich, MD
Director, Stephenson Cardiovascular MR (CMR) Centre
at the Libin Cardiovascular Institute of Alberta
Associate Professor of Cardiac Sciences and Radiology
University of Calgary
Calgary, Alberta, Canada
- describe the limitations of current clinical imaging techniques for assessing myocardial ischemia
- list current CMR approaches for assessing myocardial ischemia in patients
- explain the clinical potential of oxygenation-sensitive CMR
“Olive Oil, the Mediterranean Diet and Cardiovascular Disease Prevention”
George A. Beller, MD
Ruth C. Heede Professor of Cardiology
Professor of Internal Medicine
Director, Enhanced External Counterpulsation Program (EECP)
University of Virginia Health System
Charlottesville, VA
- recall the evidence and mechanisms by which virgin olive oil has major beneficial biological effects that enhance cardiovascular health.
- discuss the data showing that adherence to the Mediterranean Diet significantly reduces fatal and nonfatal coronary heart disease events, reduces cancer mortality, and preserves cognitive function.
[/one_fifth_last]
Grollman Lecture
“Ablation of Ventricular Tachycardia in Structural Heart Disease: Treatment of the Last Resort?”
David J. Callans, MD
Professor of Medicine
University of Pennsylvania Hospital
Presbyterian Medical Center
Philadelphia, PA
- discuss the importance of avoiding ICD therapy
- describe why ablation is effective in this setting and should be employed earlier
“Noninvasive Evaluation of Ischemic Heart Disease in Diabetics”
Jamieson Bourque, MD
Cardiovascular Disease Fellow
Cardiovascular Medicine
University of Virginia Health System
Charlottesville, VA
- describe the unique challenges in assessing ischemic heart disease non-invasively in diabetics
“Stress Perfusion CMR: Current and Future Applications”
Michael Salerno, MD
Cardiovascular Imaging Fellow
Cardiovascular Medicine
University of Virginia Health System
Charlottesville, VA
- explain the diagnostic and prognostic utility of stress perfusion CMR
- discuss new techniques in development to improve stress CMR
“Endovascular Treatment of Occlusive Arterial Disease of the Lower Extremities: Review of Evidence”
M. Ayoub Mirza, MD
Interventional Fellow
Cardiovascular Medicine
University of Virginia Health System
Charlottesville, VA
- describe the evidence for percutaneous treatment of occlusive atherosclerotic arterial disease of the legs
- identify emerging technologies for percutaneous angioplasty of the arteries of the legs
“Selecting Patients for Primary Prevention ICDs: The Importance of Comorbidities”
Andrew Darby, MD
Electrophysiology Fellow
Cardiovascular Medicine
University of Virginia Health System
Charlottesville, VA
- discuss the guidelines and pertinent trials for primary prevention ICDs in ischemic and nonischemic cardiomyopathy
- identify tools for risk stratification for sudden cardiac death
- describe how comorbidities diminish the mortality benefit with primary prevention ICDs in certain patient groups
Last Grand Rounds of the 2009-10 Academic Year: “Defibrillation Threshold Testing: Could Saving Your Life Kill You?”
Rohit Malhotra, MD
Electrophysiology Fellow
Cardiovascular Medicine
University of Virginia Health System
Charlottesville, VA
- discuss the effects of inappropriate ICD shocks
- identify methods to minimize ICD shocks
- describe the risks and benefits of DFT testing